结直肠癌,凋亡抑制蛋白,Livin,预后," /> 结直肠癌,凋亡抑制蛋白,Livin,预后,"/> Colorectal cancer,Inhibitor of apoptosis protein,Livin,Prognosis,"/>  <span style="font-family:宋体;">Expression and clinical significance of Livin in stage </span><span style="font-family:宋体;">Ⅰ<span>-</span>Ⅲ<span> colorectal cancer</span></span>

Chinese Clinical Oncology ›› 2018, Vol. 23 ›› Issue (10): 910-914.

Previous Articles     Next Articles

 Expression and clinical significance of Livin in stage - colorectal cancer

  

  1. Department of Oncology Affiliated Haikou Hospital of Xiangya Medical College, Central South University Haikou 570208
  • Received:2018-04-08 Revised:2018-07-12 Online:2018-10-31 Published:2019-03-20

Abstract:  Objective  To investigate the expression of Livin protein in stage ⅠⅢ colorectal cancer and its relationship with clinicopathological features and prognosis. Methods  From January 2007 to December 2009 100 cases of colorectal cancer 30 cases of adjacent tissues and 15 cases of normal colorectal mucosa in Peoples Hospital of Haikou were selected. The expression of Livin protein was examined by MaxVisionTM2. The relationship between Livin expression and clinicopathological features of colorectal cancer was analyzed. Cox hazardregression model was used to analyze the factors influencing overall survivalOS.

ResultsThe positive expression rates of Livin in colorectal cancer tissues adjacent tissues and normal colorectal mucosa tissues were 64.0%(64/100), 16.7%(5/30 and 0, respectively P0.05. Livin expression was correlated with TNM stage invasion depth lymph node metastasis, differentiation degree and preoperative CEA P0.05), but not with sex age and tumor sizeP0.05. Cox multivariate regression analysis showed that Livin expression and TNM stage were independent prognostic factors for OS in stage - colorectal cancerP0.05. Conclusion  Livin may be associated with the occurrence development and prognosis of colorectal cancer and may provide important guidance for clinical diagnosis and evaluation of colorectal cancer.

Key words:  , Colorectal cancer">Colorectal cancer')">">, Inhibitor of apoptosis protein, Livin, Prognosis

CLC Number: 

  • R735.3
[1] WANG Xinwei, LV Ke, SONG Zhan, QIAN Guowu, YU Sijun..  ADAM15 promotes metastasis and invasion of colorectal cancer cells by activating EGFR [J]. Chinese Clinical Oncology, 2018, 23(10): 881-885.
[2] JIANG Wen, WANG Lixue, DING Huaiyin, ZHENG Qin, XU Hanfeng, YANG Mi, ZHANG Quan’an. .  Monitoring of circulating tumor cells in patients with liver metastases from colorectal cancer undergoing microwave ablation [J]. Chinese Clinical Oncology, 2018, 23(10): 925-930.
[3] HE Zhijun, WU Lianbao, HAN Jiang. .  Effects of enhanced recovery after surgery in perioperative period of colorectal cancer [J]. Chinese Clinical Oncology, 2018, 23(10): 931-936.
[4] ZHANG Dezhi, ZHANG Yu, ZHU Shaogong.. Effect of rs10013228 polymorphism of VEGFR2 gene on prognosis of patients with R0 resection of colorectal cancer [J]. Chinese Clinical Oncology, 2018, 23(5): 424-428.
[5] YAO Bo, LU Na.. The role of radiotherapy in the management of rectal cancer with synchronous metastases [J]. Chinese Clinical Oncology, 2018, 23(5): 463-466.
[6] MENG Cunying, AN Tai, SHI Shengmei, ZHANG Chunli, LIU Yan, YUAN Donghong, MA Ying, LIU Pengfei.. Expression of DCLK1 and Bmi-1 in colorectal cancer and their clinical significance [J]. Chinese Clinical Oncology, 2018, 23(5): 419-423.
[7] WANG Shanshan, WANG Haiyan, WU Bin, ZHAO Lihong, LI Dong, XIE Yan. . Observation of apatinib mesylate treatment on colon cancer failed in multi-line chemotherapy [J]. Chinese Clinical Oncology, 2018, 23(5): 453-457.
[8] YANG Yefan, MA Zhonghua, WANG Keming.. Progression of long chain non coding RNA in the regulation of drug resistance in colorectal cancer [J]. Chinese Clinical Oncology, 2018, 23(5): 458-462.
[9] . Progression of monocolonal antibodies for colorectal cancer in 2008 [J]. Chinese Clinical Oncology, 2009, 14(1): 1-.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!